NO880606D0 - Nukleotidanaloger og fremgangsmaate for deres fremstilling. - Google Patents

Nukleotidanaloger og fremgangsmaate for deres fremstilling.

Info

Publication number
NO880606D0
NO880606D0 NO880606A NO880606A NO880606D0 NO 880606 D0 NO880606 D0 NO 880606D0 NO 880606 A NO880606 A NO 880606A NO 880606 A NO880606 A NO 880606A NO 880606 D0 NO880606 D0 NO 880606D0
Authority
NO
Norway
Prior art keywords
nucleotid
analogs
procedures
preparation
nucleotid analogs
Prior art date
Application number
NO880606A
Other languages
English (en)
Other versions
NO880606L (no
Inventor
Tsunehiko Fukuda
Ryuji Marumoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO880606D0 publication Critical patent/NO880606D0/no
Publication of NO880606L publication Critical patent/NO880606L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0834Compounds having one or more O-Si linkage
    • C07F7/0838Compounds with one or more Si-O-Si sequences
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65744Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO880606A 1987-02-12 1988-02-11 Nukleotidanaloger og fremgangsmaate for deres fremstilling. NO880606L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3000187 1987-02-12
JP33156787 1987-12-25

Publications (2)

Publication Number Publication Date
NO880606D0 true NO880606D0 (no) 1988-02-11
NO880606L NO880606L (no) 1988-08-15

Family

ID=26368254

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880606A NO880606L (no) 1987-02-12 1988-02-11 Nukleotidanaloger og fremgangsmaate for deres fremstilling.

Country Status (11)

Country Link
EP (1) EP0278501A3 (no)
CN (1) CN88100826A (no)
AU (1) AU1164588A (no)
CS (1) CS270235B2 (no)
DK (1) DK64688A (no)
FI (1) FI880628A (no)
HU (1) HUT48885A (no)
IN (1) IN166499B (no)
NO (1) NO880606L (no)
PL (1) PL270564A1 (no)
YU (1) YU28488A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813148D0 (en) * 1988-06-03 1988-07-06 Glaxo Group Ltd Chemical compounds
GB9204015D0 (en) * 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
EP0577558A2 (de) * 1992-07-01 1994-01-05 Ciba-Geigy Ag Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
US5874578A (en) * 1992-07-13 1999-02-23 Bristol-Myers Squibb Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
CN102603652A (zh) * 2011-12-27 2012-07-25 河南师范大学 5-甲酰基嘧啶碳环核苷及制备方法
CN104211748B (zh) * 2013-11-15 2017-05-31 南京济群医药科技股份有限公司 6‑羟基双脱氧鸟嘌呤核苷磷酸酯制备和用途
CN104558080A (zh) * 2015-02-03 2015-04-29 西安新通药物研究有限公司 环状磷酸酯合成的新方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5040590A (no) * 1973-07-30 1975-04-14
US4383114A (en) * 1977-02-09 1983-05-10 Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine arabinonucleosides

Also Published As

Publication number Publication date
NO880606L (no) 1988-08-15
DK64688A (da) 1988-08-13
CS89588A2 (en) 1989-10-13
DK64688D0 (da) 1988-02-09
CS270235B2 (en) 1990-06-13
FI880628A0 (fi) 1988-02-11
PL270564A1 (en) 1988-12-08
EP0278501A2 (en) 1988-08-17
AU1164588A (en) 1988-08-18
IN166499B (no) 1990-05-19
YU28488A (en) 1989-10-31
CN88100826A (zh) 1988-09-14
FI880628A (fi) 1988-08-13
HUT48885A (en) 1989-07-28
EP0278501A3 (en) 1991-01-02

Similar Documents

Publication Publication Date Title
NO881660D0 (no) Hepariner og femgangsmaate for deres fremstilling.
NO882390L (no) (ih-azol-1-ylmetyl)substituerte benzotriazolderivater og deres fremstilling.
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
NO875358D0 (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO871526L (no) Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
NO870512D0 (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO875432D0 (no) Sialinsyrederivater og fremgangsmaate for deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
NO882766D0 (no) Katalysatorer og fremgangsmaate for deres fremstilling.
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
NO883055D0 (no) Karbosilanpolymerer og fremgangsmaate for deres fremstilling.
NO880511L (no) Substituerte aminderivater og fremgangsmaater for deres fremstilling.
NO880606D0 (no) Nukleotidanaloger og fremgangsmaate for deres fremstilling.
NO883114L (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO872625D0 (no) Benzimidazoler og fremgangsmaater for deres fremstilling.
DK189488D0 (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK162087D0 (da) Piperidinforbindelser, deres fremstilling og anvendelse
NO881777L (no) Benzensulfonamidderivater og fremgangsmaate til deres fremstilling.
NO882610L (no) Polykarbonater og fremgangsmaate for deres fremstilling.
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.
NO830981L (no) Pentandionsyrederivater og fremgangsmaate for deres fremstilling.
NO873126D0 (no) Cefalosporiner og derivater derav og fremgangsmaater for deres fremstilling.
NO843158L (no) 1,6-nafthydrinderivater og fremgangsmaate for deres fresmtilling